Hearing Aid Trial Reveals Surprising Cognitive Improvements in Older Adults
New scientific data indicate that addressing hearing loss may help a meaningful segment of older adults regain everyday cognitive and functional capacities. While a recent clinical trial did not find that hearing aids directly prevented the progression from mild cognitive impairment to full dementia, researchers observed an unexpected and substantial signal regarding cognitive recovery among participants fitted with the devices.
The study, known as the CHOICE trial, was led by Dr. Hao Wu and colleagues at the Shanghai Jiao Tong University School of Medicine in China. Published in JAMA Neurology, the research investigated whether intervening with hearing aids could alter cognitive trajectories among older individuals already experiencing both moderate-to-severe hearing loss and mild cognitive impairment. Hearing loss is widely recognized by medical professionals as a key modifiable risk factor for dementia.
During the 24-month trial, researchers tracked 703 older adults with a mean age of 74.5 years. Participants were randomly divided into two groups: one group received a hearing aid intervention, while the control group received standard hearing care education. The primary goal of the study was to measure the conversion rate from mild cognitive impairment to dementia-level impairment using the Clinical Dementia Rating scale, where a score of 0.5 denotes mild impairment and 1 indicates dementia.
The primary outcome showed that 3.09 percent of participants in the hearing aid group progressed to dementia, compared to 4.74 percent in the control group. Because the overall dementia conversion rate during the two-year study period was significantly lower than initially anticipated, the researchers noted that the primary outcome was underpowered. Consequently, the primary finding was categorized as not proven rather than definitive proof of no benefit.
However, a prespecified secondary outcome yielded a striking result. The rate of cognitive improvement—defined as moving backward from a Clinical Dementia Rating score of 0.5 to a normal cognitive score of 0—was 15.34 percent in the hearing aid group, compared to just 2.36 percent in the control group. This suggested a nearly sixfold greater chance of cognitive recovery for individuals who received hearing aids.
Dr. Wu explained that these findings point toward a potential protective mechanism for a subset of older adults. Instead of merely slowing cognitive decline, treating hearing loss may allow some individuals to regain functional capabilities. Editorialists not affiliated with the trial, including Dr. Justin Golub of Columbia University Irving Medical Center, pointed out parallels with previous research, such as the 2023 ACHIEVE trial. While the ACHIEVE trial evaluated cognitively intact older adults and found no broad overall treatment effect, a subgroup analysis demonstrated substantial cognitive preservation among high-risk individuals.
Experts emphasize that the surprisingly large effect size observed in the secondary outcome of the CHOICE trial requires careful replication by independent research teams. Limitations of the study included the reliance on the subjective Clinical Dementia Rating scale and potential selection biases due to eligibility criteria. Despite these caveats, researchers underscore that hearing aids provide well-established benefits for interpersonal communication, social engagement, and overall quality of life regardless of cognitive impacts.
Medical professionals suggest that these exploratory findings warrant increased clinical attention toward managing hearing health in aging populations. As researchers continue to investigate the complex intersection between sensory deficits and cognitive health, addressing auditory decline remains a vital component of holistic elder care.
Key Takeaways on Hearing Health and Cognition
- The CHOICE trial evaluated 703 older adults with moderate-to-severe hearing loss and mild cognitive impairment.
- While hearing aids did not significantly reduce the primary dementia conversion rate, they were associated with a notably higher rate of cognitive improvement.
- Participants fitted with hearing aids demonstrated nearly six times the rate of returning to normal cognitive scores compared to the control group.
- Researchers stress that these exploratory findings are not definitive medical advice and require further replication through rigorous clinical trials.
Source: MedPage Today
